160 related articles for article (PubMed ID: 34888136)
1. GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer.
Tan L; Qu W; Wu D; Liu M; Wang Q; Ai Q; Hu H; Chen M; Chen W; Zhou H
Anal Cell Pathol (Amst); 2021; 2021():6004821. PubMed ID: 34888136
[TBL] [Abstract][Full Text] [Related]
2. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cells.
Wang XK; Zhou FF; Tao HR; Wang X; Zhang C; Su F; Wang SP; Xu LH; Pan XK; Feng MH; Xie W
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):880-885. PubMed ID: 29270747
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
[TBL] [Abstract][Full Text] [Related]
5. PMEPA1 induces EMT via a non-canonical TGF-β signalling in colorectal cancer.
Zhang L; Wang X; Lai C; Zhang H; Lai M
J Cell Mol Med; 2019 May; 23(5):3603-3615. PubMed ID: 30887697
[TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
7. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
[TBL] [Abstract][Full Text] [Related]
8. TrkC promotes colorectal cancer growth and metastasis.
Kim MS; Suh KW; Hong S; Jin W
Oncotarget; 2017 Jun; 8(25):41319-41333. PubMed ID: 28455963
[TBL] [Abstract][Full Text] [Related]
9. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
Tao Y; Han T; Zhang T; Sun C
Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1.
Quan Y; Jin R; Huang A; Zhao H; Feng B; Zang L; Zheng M
Cancer Biol Ther; 2014 Jul; 15(7):878-87. PubMed ID: 24756066
[TBL] [Abstract][Full Text] [Related]
11. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
12. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
[TBL] [Abstract][Full Text] [Related]
16. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
Li J; Tian L; Jing Z; Guo Z; Nan P; Liu F; Zou S; Yang L; Xie X; Zhu Y; Zhao Y; Sun W; Sun Y; Zhao X
Cancer Lett; 2021 Sep; 516():13-27. PubMed ID: 34062216
[TBL] [Abstract][Full Text] [Related]
18. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis.
Du F; Chen J; Liu H; Cai Y; Cao T; Han W; Yi X; Qian M; Tian D; Nie Y; Wu K; Fan D; Xia L
Cell Death Dis; 2019 Mar; 10(3):239. PubMed ID: 30858360
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
[No Abstract] [Full Text] [Related]
20. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance.
Liu Z; Chen J; Yuan W; Ruan H; Shu Y; Ji J; Wu L; Tang Q; Zhou Z; Zhang X; Cheng Y; He S; Shu X
Cancer Sci; 2019 Jan; 110(1):86-98. PubMed ID: 30320939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]